On Friday, Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) was 0.11% up from the session before settling in for the closing price of $35.66. A 52-week range for AMPH has been $34.60 – $56.88.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 19.20% over the past five years. When this article was written, the company’s average yearly earnings per share was at 17.18%. With a float of $35.79 million, this company’s outstanding shares have now reached $48.37 million.
Let’s look at the performance matrix of the company that is accounted for 1761 employees. In terms of profitability, gross margin is 51.98%, operating margin of 29.71%, and the pretax margin is 25.95%.
Amphastar Pharmaceuticals Inc (AMPH) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Amphastar Pharmaceuticals Inc stocks. The insider ownership of Amphastar Pharmaceuticals Inc is 25.56%, while institutional ownership is 74.73%. The most recent insider transaction that took place on Dec 13 ’24, was worth 361,840. In this transaction SENIOR EVP, PRODUCTION CENTER of this company sold 8,000 shares at a rate of $45.23, taking the stock ownership to the 118,469 shares. Before that another transaction happened on Dec 12 ’24, when Company’s SENIOR EVP, PRODUCTION CENTER sold 7,000 for $44.42, making the entire transaction worth $310,975. This insider now owns 118,469 shares in total.
Amphastar Pharmaceuticals Inc (AMPH) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.02 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.18% per share during the next fiscal year.
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Trading Performance Indicators
You can see what Amphastar Pharmaceuticals Inc (AMPH) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.61. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.37. Likewise, its price to free cash flow for the trailing twelve months is 10.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.01, a number that is poised to hit 0.96 in the next quarter and is forecasted to reach 4.09 in one year’s time.
Technical Analysis of Amphastar Pharmaceuticals Inc (AMPH)
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) saw its 5-day average volume 0.69 million, a positive change from its year-to-date volume of 0.68 million. As of the previous 9 days, the stock’s Stochastic %D was 28.29%. Additionally, its Average True Range was 1.57.
During the past 100 days, Amphastar Pharmaceuticals Inc’s (AMPH) raw stochastic average was set at 5.68%, which indicates a significant decrease from 24.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.96% in the past 14 days, which was higher than the 38.97% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $41.99, while its 200-day Moving Average is $43.30. Nevertheless, the first resistance level for the watch stands at $36.01 in the near term. At $36.33, the stock is likely to face the second major resistance level. The third major resistance level sits at $36.70. If the price goes on to break the first support level at $35.33, it is likely to go to the next support level at $34.96. The third support level lies at $34.64 if the price breaches the second support level.
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Key Stats
There are 48,081K outstanding shares of the company, which has a market capitalization of 1.72 billion. As of now, sales total 644,400 K while income totals 137,550 K. Its latest quarter income was 191,210 K while its last quarter net income were 40,430 K.
